Eli Lilly has determined its monoclonal antibody treatment reduces patients' COVID-19 viral load and helps them avoid hospitalization, it announced Wednesday.
The treatment involves combining two antibodies and injecting them into patients — similar to the treatment developed by Regeneron that President Trump received. Less than 1 percent of patients sick with COVID-19 and injected with the treatment went to the hospital, compared to 5.8 percent who had a placebo, Eli Lilly's study found. And at the end of 11 days, the antibody combination "significantly reduced" the amount of virus found in patients' nasal swabs.
Last month, the pharmaceutical company also announced positive results from a trial involving just one antibody. Eli Lilly is now seeking the Food and Drug Administration's emergency use authorization for the single antibody treatment. It will likely seek authorization for the combination therapy next month, after it manufactures a bigger supply and gets patients into clinical trials.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Wednesday's news sent Eli Lilly's shares up more than 3 percent in morning trading.
-
Israel: Losing the American publicFeature A recent poll finds American support for Israel's military action in Gaza has fallen from 50% to 32%
-
Unmaking AmericansFeature Trump is threatening to revoke the citizenship of foreign-born Americans. Could he do that?
-
EPA: A bonfire of climate change regulationsFeature The Environmental Protection Agency wants to roll back its 'endangerment finding,' a ruling that lets the agency regulate carbon emissions
-
US to take 15% cut of AI chip sales to ChinaSpeed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with DisneySpeed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B dealSpeed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance mergerSpeed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profitsSpeed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new highSpeed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year
-
Economists fear US inflation data less reliablespeed read The Labor Department is collecting less data for its consumer price index due to staffing shortages
-
Crypto firm Coinbase hacked, faces SEC scrutinySpeed Read The Securities and Exchange Commission has also been investigating whether Coinbase misstated its user numbers in past disclosures
